Selecting the optimal risk threshold of diabetes risk scores to identify high-risk individuals for diabetes prevention: a cost-effectiveness analysis

• Published in: Acta diabetologica 2020-04, Vol.57 (4), p.447-454
• Main Authors: Mühlenbruch, Kristin, Zhuo, Xiaohui, Bardenheier, Barbara, Shao, Hui, Laxy, Michael, Icks, Andrea, Zhang, Ping, Gregg, Edward W., Schulze, Matthias B.
• Format: Article
• Language: English
• Subjects: Cost analysis; Diabetes; Diabetes mellitus (non-insulin dependent); Health risk assessment; Health risks; Internal Medicine; Medicine; Medicine & Public Health; Metabolic Diseases; Original; Original Article; Population characteristics; Prevention; Risk groups
• ISSN: 0940-5429; 1432-5233
• DOI: 10.1007/s00592-019-01451-1

Aims Although risk scores to predict type 2 diabetes exist, cost-effectiveness of risk thresholds to target prevention interventions are unknown. We applied cost-effectiveness analysis to identify optimal thresholds of predicted risk to target a low-cost community-based intervention in the USA. Methods We used a validated Markov-based type 2 diabetes simulation model to evaluate the lifetime cost-effectiveness of alternative thresholds of diabetes risk. Population characteristics for the model were obtained from NHANES 2001–2004 and incidence rates and performance of two noninvasive diabetes risk scores (German diabetes risk score, GDRS, and ARIC 2009 score) were determined in the ARIC and Cardiovascular Health Study (CHS). Incremental cost-effectiveness ratios (ICERs) were calculated for increasing risk score thresholds. Two scenarios were assumed: 1-stage (risk score only) and 2-stage (risk score plus fasting plasma glucose (FPG) test (threshold 100 mg/dl) in the high-risk group). Results In ARIC and CHS combined, the area under the receiver operating characteristic curve for the GDRS and the ARIC 2009 score were 0.691 (0.677–0.704) and 0.720 (0.707–0.732), respectively. The optimal threshold of predicted diabetes risk (ICER